Key Takeaways from the RELATIVITY-047 Trial: Managing Advanced Melanoma

Panelists discuss how the RELATIVITY-047 trial data highlights the efficacy of nivolumab plus relatlimab in managing advanced melanoma, offering improved progression-free survival with a favorable safety profile compared to with nivolumab alone.

EP: 1.Treatment Decisions in Metastatic Melanoma: Immunotherapy vs Targeted Therapy

Now Viewing

EP: 2.Key Takeaways from the RELATIVITY-047 Trial: Managing Advanced Melanoma

Recent Videos